当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2008年第21期
编号:11672040
博乐欣与西酞普兰治疗抑郁症对照研究
http://www.100md.com 2008年7月25日 范祚君
第1页

    参见附件(1259KB,2页)。

     [摘要] 目的:探讨博乐欣与西酞普兰治疗抑郁症的疗效与安全性。方法:86例抑郁症患者随机分为2组,分别给予博乐欣与西酞普兰治疗,疗程6周。采用汉密尔顿抑郁量表(HAMD)评价疗效,同时观察不良反应。结果:治疗3,6周末,两组的HAMD总分均较治疗前显著减低(P<0.01);治疗6周末,博乐欣组与西酞普兰组的有效率分别为90.2%,87.5%(P>0.05);两组不良反应相当且轻微。结论:博乐欣与西酞普兰治疗抑郁症疗效相当,均安全有效。

    [关键词] 抑郁症;博乐欣;西酞普兰;疗效;不良反应

    [中图分类号] R971+.43 [文献标识码]B[文章编号]1673-7210(2008)07(c)-069-02

    A control study of venlafaxine and citalopram in treatment of depression

    FAN Zuo-jun

    (The First Mental Hospital of Hengyang City,Hengyang 421002,China)

    [Abstract] Objective:To investigate the efficacy and safety of venlafaxine and citalopram in treating the patients with depression. Methods:86 patients with depression were randomly divided into two groups which were treated with venlafaxine and citalopram for 6 weeks respectively. Hamilton Depression Scale(HAMD) was employed to evaluate efficacy,and side effects were observed.Results: The HAMD scores of both groups significantly reduced at weeks 3 ......

您现在查看是摘要介绍页,详见PDF附件(1259KB,2页)